196 related articles for article (PubMed ID: 17360144)
1. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
; Crystal JS; Thompson JF; Hyngstrom J; Caracò C; Zager JS; Jahkola T; Bowles TL; Pennacchioli E; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; van Akkooi A; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Neves RI; Rossi CR; Kane JM; Trocha S; Wright F; Byrd DR; Matter M; Hsueh EC; MacKenzie-Ross A; Kelley M; Terheyden P; Huston TL; Wayne JD; Neuman H; Smithers BM; Ariyan CE; Desai D; Gershenwald JE; Schneebaum S; Gesierich A; Jacobs LK; Lewis JM; McMasters KM; O'Donoghue C; van der Westhuizen A; Sardi A; Barth R; Barone R; McKinnon JG; Slingluff CL; Farma JM; Schultz E; Scheri RP; Vidal-Sicart S; Molina M; Testori AAE; Foshag LJ; Van Kreuningen L; Wang HJ; Sim MS; Scolyer RA; Elashoff DE; Cochran AJ; Faries MB
JAMA Surg; 2022 Sep; 157(9):835-842. PubMed ID: 35921122
[TBL] [Abstract][Full Text] [Related]
4. Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes.
Lin X; Sun W; Ren M; Xu Y; Wang C; Yan W; Kong Y; Balch CM; Chen Y
J Surg Oncol; 2023 Dec; 128(8):1407-1415. PubMed ID: 37689989
[TBL] [Abstract][Full Text] [Related]
5. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract][Full Text] [Related]
6. Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study.
Zhong J; Zou Z; Hu T; Sun W; Wang C; Yan W; Luo Z; Liu X; Xu Y; Chen Y
Clin Exp Med; 2023 Nov; 23(7):4003-4010. PubMed ID: 37300655
[TBL] [Abstract][Full Text] [Related]
7. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.
Masoud SJ; Perone JA; Farrow NE; Mosca PJ; Tyler DS; Beasley GM
Curr Treat Options Oncol; 2018 Sep; 19(11):55. PubMed ID: 30232648
[TBL] [Abstract][Full Text] [Related]
8. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Outcomes Between Surveillance Ultrasound and Completion Lymph Node Dissection in Children and Adolescents With Sentinel Lymph Node-Positive Cutaneous Melanoma.
Scoville SD; Stanek JR; Rinehardt H; Sutthatarn P; Abdelhafeez AH; Talbot LJ; Malek M; Leraas HJ; Tracy ET; Chen SY; Kim ES; Lotakis DM; Ehrlich PF; Favela JG; Le HD; Davidson J; Wilson CA; Seemann NM; Osman Y; Piche N; Hoang V; Petroze RT; Polites SF; McKay KG; Correa H; Lovvorn HN; Lee YM; Balagani A; Dasgupta R; Aldrink JH
Ann Surg; 2024 Mar; 279(3):536-541. PubMed ID: 37487006
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract][Full Text] [Related]
11. Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma: The Role of the First Postoperative Ultrasound.
Keller J; Stern S; Chang SC; Marcus R; Weiss J; Nassoiy S; Christopher W; Fischer T; Essner R
Ann Surg Oncol; 2022 Dec; 29(13):8469-8477. PubMed ID: 35989390
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients.
Song JY; Ryu YJ; Lee HK; Lee DH; Choi YD; Shim HJ; Yun SJ
Pigment Cell Melanoma Res; 2024 May; 37(3):332-342. PubMed ID: 38013393
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm).
Holmberg CJ; Mikiver R; Isaksson K; Ingvar C; Moncrieff M; Nielsen K; Ny L; Lyth J; Olofsson Bagge R
Ann Surg Oncol; 2023 Dec; 30(13):8026-8033. PubMed ID: 37574516
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
Maddineni S; Dizon MP; Muralidharan V; Young LA; Sunwoo JB; Baik FM; Swetter SM
Ann Surg Oncol; 2024 Apr; 31(4):2737-2746. PubMed ID: 38216800
[TBL] [Abstract][Full Text] [Related]
15. Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.
Hoshimoto S; Shingai T; Morton DL; Kuo C; Faries MB; Chong K; Elashoff D; Wang HJ; Elashoff RM; Hoon DS
J Clin Oncol; 2012 Nov; 30(31):3819-26. PubMed ID: 23008288
[TBL] [Abstract][Full Text] [Related]
16. Surgeon decision-making for management of positive sentinel lymph nodes in the post-Multicenter Selective Lymphadenectomy Trial II era: A survey study.
Hui JYC; Burke E; Broman KK; Marmor S; Jensen E; Tuttle TM; Zager JS
J Surg Oncol; 2021 Feb; 123(2):646-653. PubMed ID: 33289125
[TBL] [Abstract][Full Text] [Related]
17. Primary Melanoma Histopathologic Predictors of Sentinel Lymph Node Positivity: A Proposed Scoring System for Risk Assessment and Patient Selection in a Clinical Setting.
Jeremić J; Radenović K; Jurišić M; Suđecki B; Marinković M; Mihaljević J; Radosavljević I; Jovanović M; Stojanović M; Milić N; Pavlović V; Stojičić M; Inić Z; Jović M
Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003969
[No Abstract] [Full Text] [Related]
18. A machine-learning approach based on multiparametric MRI to identify the risk of non-sentinel lymph node metastasis in patients with early-stage breast cancer.
Yu H; Li Q; Xie F; Wu S; Chen Y; Huang C; Xu Y; Niu Q
Acta Radiol; 2024 Feb; 65(2):185-194. PubMed ID: 38115683
[TBL] [Abstract][Full Text] [Related]
19. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
Downey J; Hamm J; Baliski C
Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single-center retrospective study.
Hu T; Xu Y; Yan W; Wang C; Sun W; Kong Y; Chen Y
Cancer Rep (Hoboken); 2023 Dec; 7(2):e1958. PubMed ID: 38148035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
